JP Stock MarketDetailed Quotes

6697 Techpoint

Watchlist

1171
00.00%

20min DelayMarket Closed Dec 30 15:30 JST

21.78BMarket Cap8.74P/E (Static)

Techpoint Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-45.83%5.4M

-41.80%2.35M

-14.68%3M

10.70%21.72M

-25.27%4.19M

179.32%9.97M

-29.12%4.05M

-25.80%3.52M

37.72%19.62M

196.72%5.61M

Net income from continuing operations

-2.75%5.05M

7.06%4.34M

29.74%4.38M

0.83%17.81M

3.16%5.19M

25.03%5.2M

-1.27%4.05M

-22.87%3.38M

2.18%17.66M

10.48%5.03M

Operating gains losses

--0

---132K

----

Depreciation and amortization

-27.59%84K

-10.00%90K

-8.91%92K

0.24%419K

-2.86%102K

9.43%116K

-5.66%100K

0.00%101K

4.50%418K

12.90%105K

Securities amortization

----

-140.76%-378K

-1,270.77%-761K

-637.50%-295K

----

-380.36%-157K

-65.05%65K

-161.54%-40K

Asset impairment expenditure

86.87%740K

-417.48%-740K

16.28%50K

-6.70%863K

10.74%567K

633.33%396K

-180.79%-143K

-76.37%43K

64.88%925K

45.45%512K

Unrealized gains and losses of investment securities

---90K

---85K

---58K

----

--0

----

Remuneration paid in stock

-1.48%400K

7.34%395K

10.22%399K

-14.40%1.55M

3.23%416K

-3.33%406K

-22.53%368K

-29.71%362K

-1.73%1.81M

-23.67%403K

Deferred tax

-18.39%-367K

-2.50%-246K

25.77%-265K

16.08%-1.4M

-17.42%-492K

24.39%-310K

42.31%-240K

15.40%-357K

-11,213.33%-1.67M

-271.02%-419K

Other non cashItems

81.82%180K

47.62%186K

0.56%178K

1.48%752K

100.00%350K

-47.62%99K

-32.62%126K

-6.84%177K

0.27%741K

-1.13%175K

Change In working capital

-91.68%377K

-425.47%-1.96M

-4,123.33%-1.27M

837.39%2.49M

-947.77%-1.65M

576.66%4.53M

-136.11%-373K

88.55%-30K

95.03%-337K

96.19%-157K

-Change in receivables

-97.98%2K

-259.46%-133K

89.13%-5K

-63.64%84K

780.00%68K

320.00%99K

-166.07%-37K

-120.00%-46K

205.96%231K

89.01%-10K

-Change in inventory

-187.30%-1.4M

-371.23%-1.19M

-1,623.66%-1.6M

399.46%3.33M

421.05%1.39M

304.74%1.6M

-64.76%438K

94.95%-93K

78.53%-1.11M

116.17%266K

-Change in prepaid assets

1,211.11%200K

---218K

169.89%130K

-212.50%-423K

-4,480.00%-219K

-114.40%-18K

--0

-158.68%-186K

267.11%376K

101.27%5K

-Change in payables and accrued expense

-63.20%548K

50.18%-273K

252.55%966K

314.71%423K

-9.39%-792K

452.84%1.49M

-500.00%-548K

-75.34%274K

123.61%102K

50.34%-724K

-Change in other current assets

-186.96%-20K

425.00%42K

1,800.00%38K

-484.62%-50K

-538.46%-83K

155.56%23K

-11.11%8K

-75.00%2K

-7.14%13K

-425.00%-13K

-Change in other current liabilities

-96.74%-181K

23.33%-115K

-15.06%-191K

-9.07%-782K

-120.00%-374K

57.01%-92K

17.13%-150K

-9.21%-166K

8.78%-717K

15.00%-170K

-Change in other working capital

-14.58%1.22M

10.71%-75K

-425.41%-602K

-112.60%-97K

-433.54%-1.63M

280.11%1.43M

47.50%-84K

189.06%185K

1,825.00%770K

244.67%489K

Cash from discontinued investing activities

Operating cash flow

-45.83%5.4M

-41.80%2.35M

-14.68%3M

10.70%21.72M

-25.27%4.19M

179.32%9.97M

-29.12%4.05M

-25.80%3.52M

37.72%19.62M

196.72%5.61M

Investing cash flow

Cash flow from continuing investing activities

302.68%21.92M

8.45%9.48M

94.32%-329K

2.03%-18.18M

45.29%-10.32M

-1,317.79%-10.81M

1,972.27%8.75M

-478.52%-5.79M

-1,668.81%-18.56M

-5,445.04%-18.87M

Net PPE purchase and sale

27.03%-54K

-5.56%-57K

84.21%-9K

39.14%-311K

-13.51%-126K

-89.74%-74K

53.04%-54K

76.83%-57K

-79.93%-511K

-1,010.00%-111K

Net business purchase and sale

----

---1.7M

--0

----

--0

Net investment purchase and sale

343.05%21.97M

8.43%9.54M

94.42%-320K

10.39%-16.17M

45.64%-10.2M

-1,075.19%-9.04M

1,538.55%8.8M

-659.47%-5.73M

-1,330.27%-18.05M

-5,267.22%-18.76M

Cash from discontinued investing activities

Investing cash flow

302.68%21.92M

8.45%9.48M

94.32%-329K

2.03%-18.18M

45.29%-10.32M

-1,317.79%-10.81M

1,972.27%8.75M

-478.52%-5.79M

-1,668.81%-18.56M

-5,445.04%-18.87M

Financing cash flow

Cash flow from continuing financing activities

-1.71%-4.7M

45.16%-17K

-0.53%-4.59M

-2.31%-9.26M

-86.36%-41K

-1.54%-4.63M

-14.81%-31K

-2.61%-4.56M

-6,602.96%-9.05M

81.67%-22K

Net common stock issuance

-139.13%-110K

21.95%-32K

-11.43%-39K

27.19%-166K

-18.92%-44K

20.69%-46K

19.61%-41K

57.32%-35K

23.75%-228K

69.92%-37K

Cash dividends paid

-0.98%-4.63M

--0

-1.05%-4.6M

-1.17%-9.14M

--0

-1.21%-4.58M

--0

-1.13%-4.56M

---9.03M

--0

Proceeds from stock option exercised by employees

1,000.00%33K

50.00%15K

96.55%57K

-78.57%45K

-80.00%3K

-90.00%3K

-58.33%10K

-79.43%29K

28.05%210K

400.00%15K

Cash from discontinued financing activities

Financing cash flow

-1.71%-4.7M

45.16%-17K

-0.53%-4.59M

-2.31%-9.26M

-86.36%-41K

-1.54%-4.63M

-14.81%-31K

-2.61%-4.56M

-6,602.96%-9.05M

81.67%-22K

Net cash flow

Beginning cash position

-6.86%23.58M

-6.36%11.76M

-29.50%13.67M

-29.17%19.39M

-39.27%19.84M

-22.76%25.31M

-52.92%12.56M

-29.17%19.39M

126.57%27.38M

29.37%32.67M

Current changes in cash

513.42%22.61M

-7.35%11.82M

71.99%-1.92M

28.37%-5.72M

53.52%-6.17M

-5,481.63%-5.47M

109.10%12.76M

-864.32%-6.84M

-152.22%-7.99M

-725.62%-13.28M

End cash Position

132.77%46.19M

-6.86%23.58M

-6.36%11.76M

-29.50%13.67M

-39.27%19.84M

-22.76%25.31M

-52.92%12.56M

-29.17%19.39M

Free cash from

-45.97%5.35M

-42.45%2.3M

-13.53%2.99M

12.03%21.41M

-26.05%4.07M

180.31%9.9M

-28.63%3.99M

-23.00%3.46M

36.86%19.11M

192.39%5.5M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-45.83%5.4M	-41.80%2.35M	-14.68%3M	10.70%21.72M	-25.27%4.19M	179.32%9.97M	-29.12%4.05M	-25.80%3.52M	37.72%19.62M	196.72%5.61M
Net income from continuing operations	-2.75%5.05M	7.06%4.34M	29.74%4.38M	0.83%17.81M	3.16%5.19M	25.03%5.2M	-1.27%4.05M	-22.87%3.38M	2.18%17.66M	10.48%5.03M
Operating gains losses	--0	--0	---132K	----	----	----	----	----	----	----
Depreciation and amortization	-27.59%84K	-10.00%90K	-8.91%92K	0.24%419K	-2.86%102K	9.43%116K	-5.66%100K	0.00%101K	4.50%418K	12.90%105K
Securities amortization	----	----	-140.76%-378K	-1,270.77%-761K	-637.50%-295K	----	----	-380.36%-157K	-65.05%65K	-161.54%-40K
Asset impairment expenditure	86.87%740K	-417.48%-740K	16.28%50K	-6.70%863K	10.74%567K	633.33%396K	-180.79%-143K	-76.37%43K	64.88%925K	45.45%512K
Unrealized gains and losses of investment securities	---90K	---85K	---58K	----	----	--0	--0	--0	----	----
Remuneration paid in stock	-1.48%400K	7.34%395K	10.22%399K	-14.40%1.55M	3.23%416K	-3.33%406K	-22.53%368K	-29.71%362K	-1.73%1.81M	-23.67%403K
Deferred tax	-18.39%-367K	-2.50%-246K	25.77%-265K	16.08%-1.4M	-17.42%-492K	24.39%-310K	42.31%-240K	15.40%-357K	-11,213.33%-1.67M	-271.02%-419K
Other non cashItems	81.82%180K	47.62%186K	0.56%178K	1.48%752K	100.00%350K	-47.62%99K	-32.62%126K	-6.84%177K	0.27%741K	-1.13%175K
Change In working capital	-91.68%377K	-425.47%-1.96M	-4,123.33%-1.27M	837.39%2.49M	-947.77%-1.65M	576.66%4.53M	-136.11%-373K	88.55%-30K	95.03%-337K	96.19%-157K
-Change in receivables	-97.98%2K	-259.46%-133K	89.13%-5K	-63.64%84K	780.00%68K	320.00%99K	-166.07%-37K	-120.00%-46K	205.96%231K	89.01%-10K
-Change in inventory	-187.30%-1.4M	-371.23%-1.19M	-1,623.66%-1.6M	399.46%3.33M	421.05%1.39M	304.74%1.6M	-64.76%438K	94.95%-93K	78.53%-1.11M	116.17%266K
-Change in prepaid assets	1,211.11%200K	---218K	169.89%130K	-212.50%-423K	-4,480.00%-219K	-114.40%-18K	--0	-158.68%-186K	267.11%376K	101.27%5K
-Change in payables and accrued expense	-63.20%548K	50.18%-273K	252.55%966K	314.71%423K	-9.39%-792K	452.84%1.49M	-500.00%-548K	-75.34%274K	123.61%102K	50.34%-724K
-Change in other current assets	-186.96%-20K	425.00%42K	1,800.00%38K	-484.62%-50K	-538.46%-83K	155.56%23K	-11.11%8K	-75.00%2K	-7.14%13K	-425.00%-13K
-Change in other current liabilities	-96.74%-181K	23.33%-115K	-15.06%-191K	-9.07%-782K	-120.00%-374K	57.01%-92K	17.13%-150K	-9.21%-166K	8.78%-717K	15.00%-170K
-Change in other working capital	-14.58%1.22M	10.71%-75K	-425.41%-602K	-112.60%-97K	-433.54%-1.63M	280.11%1.43M	47.50%-84K	189.06%185K	1,825.00%770K	244.67%489K
Cash from discontinued investing activities
Operating cash flow	-45.83%5.4M	-41.80%2.35M	-14.68%3M	10.70%21.72M	-25.27%4.19M	179.32%9.97M	-29.12%4.05M	-25.80%3.52M	37.72%19.62M	196.72%5.61M
Investing cash flow
Cash flow from continuing investing activities	302.68%21.92M	8.45%9.48M	94.32%-329K	2.03%-18.18M	45.29%-10.32M	-1,317.79%-10.81M	1,972.27%8.75M	-478.52%-5.79M	-1,668.81%-18.56M	-5,445.04%-18.87M
Net PPE purchase and sale	27.03%-54K	-5.56%-57K	84.21%-9K	39.14%-311K	-13.51%-126K	-89.74%-74K	53.04%-54K	76.83%-57K	-79.93%-511K	-1,010.00%-111K
Net business purchase and sale	----	----	----	---1.7M	--0	----	----	----	--0	--0
Net investment purchase and sale	343.05%21.97M	8.43%9.54M	94.42%-320K	10.39%-16.17M	45.64%-10.2M	-1,075.19%-9.04M	1,538.55%8.8M	-659.47%-5.73M	-1,330.27%-18.05M	-5,267.22%-18.76M
Cash from discontinued investing activities
Investing cash flow	302.68%21.92M	8.45%9.48M	94.32%-329K	2.03%-18.18M	45.29%-10.32M	-1,317.79%-10.81M	1,972.27%8.75M	-478.52%-5.79M	-1,668.81%-18.56M	-5,445.04%-18.87M
Financing cash flow
Cash flow from continuing financing activities	-1.71%-4.7M	45.16%-17K	-0.53%-4.59M	-2.31%-9.26M	-86.36%-41K	-1.54%-4.63M	-14.81%-31K	-2.61%-4.56M	-6,602.96%-9.05M	81.67%-22K
Net common stock issuance	-139.13%-110K	21.95%-32K	-11.43%-39K	27.19%-166K	-18.92%-44K	20.69%-46K	19.61%-41K	57.32%-35K	23.75%-228K	69.92%-37K
Cash dividends paid	-0.98%-4.63M	--0	-1.05%-4.6M	-1.17%-9.14M	--0	-1.21%-4.58M	--0	-1.13%-4.56M	---9.03M	--0
Proceeds from stock option exercised by employees	1,000.00%33K	50.00%15K	96.55%57K	-78.57%45K	-80.00%3K	-90.00%3K	-58.33%10K	-79.43%29K	28.05%210K	400.00%15K
Cash from discontinued financing activities
Financing cash flow	-1.71%-4.7M	45.16%-17K	-0.53%-4.59M	-2.31%-9.26M	-86.36%-41K	-1.54%-4.63M	-14.81%-31K	-2.61%-4.56M	-6,602.96%-9.05M	81.67%-22K
Net cash flow
Beginning cash position	-6.86%23.58M	-6.36%11.76M	-29.50%13.67M	-29.17%19.39M	-39.27%19.84M	-22.76%25.31M	-52.92%12.56M	-29.17%19.39M	126.57%27.38M	29.37%32.67M
Current changes in cash	513.42%22.61M	-7.35%11.82M	71.99%-1.92M	28.37%-5.72M	53.52%-6.17M	-5,481.63%-5.47M	109.10%12.76M	-864.32%-6.84M	-152.22%-7.99M	-725.62%-13.28M
End cash Position	132.77%46.19M	-6.86%23.58M	-6.36%11.76M	-29.50%13.67M	-29.50%13.67M	-39.27%19.84M	-22.76%25.31M	-52.92%12.56M	-29.17%19.39M	-29.17%19.39M
Free cash from	-45.97%5.35M	-42.45%2.3M	-13.53%2.99M	12.03%21.41M	-26.05%4.07M	180.31%9.9M	-28.63%3.99M	-23.00%3.46M	36.86%19.11M	192.39%5.5M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.